A carregar...

Protease‐activated receptor antagonists prevent thrombosis when dual antiplatelet therapy is insufficient in an occlusive thrombosis microfluidic model

Abstract Background Platelet activation and arterial thrombosis on a ruptured atherosclerotic plaque is a major cause of myocardial infarction. Dual antiplatelet therapy (DAPT), the combination of platelet aggregation inhibitors, aspirin and a P2Y12 antagonist, is used to prevent arterial thrombosis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jess Berry, Matthew T. Harper
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2022-03-01
Colecção:Research and Practice in Thrombosis and Haemostasis
Assuntos:
Acesso em linha:https://doi.org/10.1002/rth2.12703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!